We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+26.18%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$280B
AUM Growth
+$58B
Cap. Flow
-$9.91B
Cap. Flow %
-3.53%
Top 10 Hldgs %
32.38%
Holding
11,014
New
1,506
Increased
4,384
Reduced
3,586
Closed
1,324

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$861M
2
AAPL icon
Apple
AAPL
+$417M
3
JPM icon
JPMorgan Chase
JPM
+$350M
4
TMUS icon
T-Mobile US
TMUS
+$337M
5
AON icon
Aon
AON
+$296M

Sector Composition

Rank Sector Weight
1 Healthcare 3.54%
2 Technology 3.36%
3 Financials 2.95%
4 Consumer Discretionary 2.92%
5 Industrials 2.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VSTM icon
9351
Verastem
VSTM
$590M
$23K ﹤0.01%
1,092
-44,059
-98% -$1.17M
PTE
9352
DELISTED
PolarityTE, Inc. Common Stock
PTE
$23K ﹤0.01%
752
-520
-41% -$13.8K
PTE
9353
PUT
DELISTED
PolarityTE, Inc. Common Stock
PTE
$23K ﹤0.01%
740
-76
-9% -$2.02K
CHGA
9354
Change Agents Corporation Common Stock
CHGA
$2.89M
$22K ﹤0.01%
78
-5
-6% -$1.22K
CRNT icon
9355
CALL
Ceragon Networks
CRNT
$198M
$22K ﹤0.01%
+10,200
New +$21.4K
DXLG icon
9356
Destination XL Group
DXLG
$36.4M
$22K ﹤0.01%
33,624
+78
+0.2% +$35
LPCN icon
9357
CALL
Lipocine
LPCN
$17.4M
$22K ﹤0.01%
1,018
+212
+26% +$2.75K
MRKR icon
9358
PUT
Marker Therapeutics
MRKR
$19M
$22K ﹤0.01%
+1,040
New +$22.7K
TRIB
9359
Trinity Biotech
TRIB
$8.05M
$22K ﹤0.01%
+67
New +$15.3K
AUD
9360
CALL
DELISTED
Audacy, Inc.
AUD
$22K ﹤0.01%
15,600
-2,700
-15% -$3.82K
AUD
9361
PUT
DELISTED
Audacy, Inc.
AUD
$22K ﹤0.01%
15,900
-6,100
-28% -$8.63K
AMPE
9362
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$22K ﹤0.01%
115
-517
-82% -$86K
SMRT
9363
DELISTED
Stein Mart Inc
SMRT
$22K ﹤0.01%
+52,150
New +$18.8K
CBAT icon
9364
CBAK Energy Technology Ltd
CBAT
$62.5M
$21K ﹤0.01%
27,078
-59,222
-69% -$31.2K
MMLP icon
9365
CALL
Martin Midstream Partners
MMLP
$95.1M
$21K ﹤0.01%
+18,000
New +$39K
VEON icon
9366
PUT
VEON
VEON
$3.94B
$21K ﹤0.01%
+468
New +$18.8K
BLNE
9367
Beeline Holdings
BLNE
$32.8M
$21K ﹤0.01%
+73
New +$22.8K
SEAC
9368
DELISTED
Seachange International Inc
SEAC
$21K ﹤0.01%
681
-12,678
-95% -$593K
HIL
9369
CALL
DELISTED
Hill International, Inc. Common Stock
HIL
$21K ﹤0.01%
+13,900
New +$23.3K
TYME
9370
CALL
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$21K ﹤0.01%
16,000
-11,500
-42% -$15.7K
CBL
9371
CALL
DELISTED
CBL& Associates Properties, Inc.
CBL
$21K ﹤0.01%
76,400
+6,400
+9% +$1.7K
FPAC.WS
9372
DELISTED
Far Point Acquisition Corporation Warrants, exercisable for one share of Class A Common Stock for $1
FPAC.WS
$21K ﹤0.01%
41,337
+4,653
+13% +$2.73K
CTXR icon
9373
Citius Pharmaceuticals
CTXR
$21.3M
$20K ﹤0.01%
697
+271
+64% +$5.93K
BCIC
9374
BCP Investment Corp
BCIC
$94.7M
$20K ﹤0.01%
1,822
-7,057
-79% -$79.6K
RMTI icon
9375
CALL
Rockwell Medical
RMTI
$29.6M
$20K ﹤0.01%
94
-234
-71% -$55.3K

Similar funds

Ken Griffin's Q2 2020 Portfolio in Review

As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.

Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.

  • Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
  • Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
  • Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
  • Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
  • Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
  • Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
  • Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.

Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.